Literature DB >> 16936882

Discrimination of basal cell carcinoma from normal dermal stroma by quantitative multiphoton imaging.

Sung-Jan Lin1, Shiou-Hwa Jee, Chien-Jui Kuo, Ruei-Jr Wu, Wei-Chou Lin, Jau-Shiuh Chen, Yi-Hua Liao, Chih-Jung Hsu, Tsen-Fang Tsai, Yang-Fang Chen, Chen-Yuan Dong.   

Abstract

We performed multiphoton fluorescence (MF) and second-harmonic generation (SHG) imaging on human basal cell carcinoma samples. In the dermis, basal cell carcinomas can be identified by masses of autofluorescent cells with relatively large nuclei and marked peripheral palisading. In the normal dermis, SHG from dermal collagen contributes largely to the multiphoton signal. However, within the cancer stroma, SHG signals diminish and are replaced by autofluorescent signals, indicating that normal collagen structures responsible for SHG have been altered. To better delineate the cancer cells and cancer stroma from the normal dermis, a quantitative MF to SHG index is developed. We demonstrate that this index can be used to differentiate cancer cells and adjacent cancer stroma from the normal dermis. Our work shows that MF and SHG imaging can be an alternative for Mohs' surgery in the real-time guidance of the secure removal of basal cell carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16936882     DOI: 10.1364/ol.31.002756

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  40 in total

1.  Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure.

Authors:  Xiyi Chen; Oleg Nadiarynkh; Sergey Plotnikov; Paul J Campagnola
Journal:  Nat Protoc       Date:  2012-03-08       Impact factor: 13.491

2.  Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue.

Authors:  David R Rivera; Christopher M Brown; Dimitre G Ouzounov; Ina Pavlova; Demirhan Kobat; Watt W Webb; Chris Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Phase Matching considerations in Second Harmonic Generation from tissues: Effects on emission directionality, conversion efficiency and observed morphology.

Authors:  Ronald Lacomb; Oleg Nadiarnykh; Sallie S Townsend; Paul J Campagnola
Journal:  Opt Commun       Date:  2008-04-01       Impact factor: 2.310

4.  Determination of collagen nanostructure from second-order susceptibility tensor analysis.

Authors:  Ping-Jung Su; Wei-Liang Chen; Yang-Fang Chen; Chen-Yuan Dong
Journal:  Biophys J       Date:  2011-04-20       Impact factor: 4.033

5.  Maximum imaging depth of two-photon autofluorescence microscopy in epithelial tissues.

Authors:  Nicholas J Durr; Christian T Weisspfennig; Benjamin A Holfeld; Adela Ben-Yakar
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

6.  Correlation between polarization sensitive optical coherence tomography and second harmonic generation microscopy in skin.

Authors:  Viet-Hoan Le; Seunghun Lee; Bumju Kim; Yeoreum Yoon; Calvin J Yoon; Wan Kyun Chung; Ki Hean Kim
Journal:  Biomed Opt Express       Date:  2015-06-16       Impact factor: 3.732

7.  Scattering anisotropy-weighted mesoscopic imaging.

Authors:  Zhengbin Xu; Ally-Khan Somani; Young L Kim
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

8.  Tri-modal confocal mosaics detect residual invasive squamous cell carcinoma in Mohs surgical excisions.

Authors:  Dan Gareau; Anna Bar; Nicholas Snaveley; Ken Lee; Nathaniel Chen; Neil Swanson; Eric Simpson; Steve Jacques
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

9.  Quantitative second harmonic generation imaging of the diseased state osteogenesis imperfecta: experiment and simulation.

Authors:  Ronald Lacomb; Oleg Nadiarnykh; Paul J Campagnola
Journal:  Biophys J       Date:  2008-02-15       Impact factor: 4.033

10.  Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.

Authors:  Oleg Nadiarnykh; Ronald B LaComb; Molly A Brewer; Paul J Campagnola
Journal:  BMC Cancer       Date:  2010-03-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.